SCHEMBL16127859

SCHEMBL16127859

N#Cc1cc(Cl)ccc1NC(=O)c1ccccc1C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.54
▸ MAPT P10636 3/20 0.54
▸ LMNA P02545 2/20 0.54
▸ GAA P10253 2/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ HTT P42858 1/20 0.51
▸ SERPINE1 P05121 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ KCNMA1 Q12791 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ HPGD P15428 2/20 0.47
▸ AKR1C4 P17516 1/20 0.47
▸ AKR1C3 P42330 1/20 0.47
▸ AKR1C2 P52895 1/20 0.47
▸ AKR1C1 Q04828 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23864691 0.88 ALDH1A1 (0.47) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL16088604 0.88 KDM4E (0.48) ALDH1A1MAPTLMNAGAAHTT
SCHEMBL13102688 0.85 KCNMA1 (0.60) ALDH1A1MAPTGAASERPINE1KDM4E
SCHEMBL16088610 0.84 KMT2A (0.55) ALDH1A1MAPTLMNAGAAHTT
SCHEMBL11490765 0.83 GAA (0.58) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL4293229 0.79 KDM4E (0.48) ALDH1A1MAPTLMNAGAAHTT
SCHEMBL7822988 0.79 MEN1 (0.63) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL16127918 0.78 HTT (0.45) ALDH1A1MAPTLMNAGAATDP1
SCHEMBL16088619 0.77 PLK1 (0.51) HTT
SCHEMBL23864523 0.77 ALDH1A1 (0.43) ALDH1A1MAPTLMNAGAATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968330-B1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS SCRIPPS RESEARCH INST (US) 2021-09-29 — — EP disclosed
US-11045476-B2 Compounds and methods for inducing chondrogenesis THE SCRIPPS RESEARCH INSTITUTE (US) 2021-06-29 — — US disclosed
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE SCRIPPS RESEARCH INSTITUTE 2020-06-18 — — US disclosed
US-9452170-B2 Compounds and methods for inducing chondrogenesis THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-09-27 — — US disclosed
US-9452170-B2 Compounds and methods for inducing chondrogenesis THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-09-27 — — US disclosed
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-02-18 — — US disclosed
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2016-02-18 — — US disclosed
WO-2014151953-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS THE CALIFORNIA INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2014-09-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11045476-B2 Compounds and methods for inducing chondrogenesis COL2A1, BMP4, COL1A1 ALDH1A1 52/4885MAPT 4647/4885LMNA 1445/4885
US-20160045514-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 ALDH1A1 52/4885MAPT 4647/4885LMNA 1445/4885
US-20200188407-A1 COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS COL2A1, BMP4, COL1A1 ALDH1A1 52/4885MAPT 4647/4885LMNA 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback